108 related articles for article (PubMed ID: 7953195)
1. Structure-activity relationships of unsaturated long chain fatty acids in relation to the inhibition of gastric H+,K(+)-ATPase.
Murakami S; Muramatsu M; Araki H; Otomo S
Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):57-66. PubMed ID: 7953195
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory action of polyunsaturated fatty acids on IMP dehydrogenase.
Mizushina Y; Dairaku I; Yanaka N; Takeuchi T; Ishimaru C; Sugawara F; Yoshida H; Kato N
Biochimie; 2007 May; 89(5):581-90. PubMed ID: 17383068
[TBL] [Abstract][Full Text] [Related]
3. 2-[(2-Aminobenzyl)sulfinyl]-1-(2-pyridyl)-1,4,5,6-tetrahydrocyclopent[d]imidazoles as a novel class of gastric H+/K+-ATPase inhibitors.
Yamada M; Yura T; Morimoto M; Harada T; Yamada K; Honma Y; Kinoshita M; Sugiura M
J Med Chem; 1996 Jan; 39(2):596-604. PubMed ID: 8558532
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of gastric (H+ + K+)-ATPase by unsaturated long-chain fatty acids.
Im WB; Blakeman DP
Biochim Biophys Acta; 1982 Nov; 692(3):355-60. PubMed ID: 6293567
[TBL] [Abstract][Full Text] [Related]
5. Influence of lipids on gap-junction-mediated intercellular communication between Chinese hamster cells in vitro.
Aylsworth CF; Trosko JE; Welsch CW
Cancer Res; 1986 Sep; 46(9):4527-33. PubMed ID: 3731106
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for unsaturated fatty acids and fatty alcohols to induce optimal biological responses: an approach using model membranes.
Castaing M; Camplo M; Kraus JL
Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):131-50. PubMed ID: 8210693
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a relationship between activity and the tetraprotomeric assembly of solubilized pig gastric H/K-ATPase.
Abe K; Kaya S; Taniguchi K; Hayashi Y; Imagawa T; Kikumoto M; Oiwa K; Sakaguchi K
J Biochem; 2005 Sep; 138(3):293-301. PubMed ID: 16169880
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the activities and the oligomeric forms of pig gastric H/K-ATPase.
Abe K; Kaya S; Hayashi Y; Imagawa T; Kikumoto M; Oiwa K; Katoh T; Yazawa M; Taniguchi K
Biochemistry; 2003 Dec; 42(51):15132-8. PubMed ID: 14690423
[TBL] [Abstract][Full Text] [Related]
10. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
Kinoshita M; Saito N; Noto T; Tamaki H
J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
[TBL] [Abstract][Full Text] [Related]
11. Novel pyrimidines as acid pump antagonists (APAs).
Yoon YA; Park CS; Cha MH; Choi H; Sim JY; Kim JG
Bioorg Med Chem Lett; 2010 Oct; 20(19):5735-8. PubMed ID: 20810280
[TBL] [Abstract][Full Text] [Related]
12. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of individual saturated and unsaturated fatty acids on cell growth and death induction in the human pancreatic beta-cell line NES2Y.
Fürstova V; Kopska T; James RF; Kovar J
Life Sci; 2008 Mar; 82(13-14):684-91. PubMed ID: 18272185
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor and ion binding sites on the gastric H,K-ATPase.
Munson K; Garcia R; Sachs G
Biochemistry; 2005 Apr; 44(14):5267-84. PubMed ID: 15807521
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000.
Smolka AJ; Goldenring JR; Gupta S; Hammond CE
BMC Gastroenterol; 2004 Feb; 4():4. PubMed ID: 15028114
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gastric H+, K+-ATPase by 3-amino-5-methyl-2-(2-methyl-3-thienyl)imidazo[1,2-a]thieno[3,2-c]pyrid ine, SPI-447.
Ushiro T; Tsukimi Y; Tanaka H
Jpn J Pharmacol; 1997 Nov; 75(3):303-6. PubMed ID: 9434264
[TBL] [Abstract][Full Text] [Related]
17. Expression of gastric ghrelin and H(+)-K(+)-ATPase mRNA in weanling piglets and effect of ghrelin on H(+)-K(+)-ATPase expression and activity in gastric mucosal cells in vitro.
Du GM; Shi ZM; Wei XH; Liu MJ; Zhang L; Zhao RQ
Res Vet Sci; 2007 Feb; 82(1):99-104. PubMed ID: 16920167
[TBL] [Abstract][Full Text] [Related]
18. Effects of C18 fatty acids on breast carcinoma cells in culture.
Bégin ME; Ells G
Anticancer Res; 1987; 7(2):215-7. PubMed ID: 3592634
[TBL] [Abstract][Full Text] [Related]
19. Gastric H-K-ATPase and acid-resistant surface proteins.
Thangarajah H; Wong A; Chow DC; Crothers JM; Forte JG
Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G953-61. PubMed ID: 12016120
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.
Gedda K; Briving C; Svensson K; Maxvall I; Andersson K
Biochem Pharmacol; 2007 Jan; 73(2):198-205. PubMed ID: 17081503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
